RGTI
Rigetti Computing
-- 18.3700 LAES
SEALSQ Corp
-- 9.618 TSLA
Tesla
-- 436.810 NVDA
NVIDIA
-- 135.990 KULR
KULR Technology
-- 4.6600 
$Kiniksa Pharmaceuticals International (KNSA.US)$In 2021, th...
$Kiniksa Pharmaceuticals International (KNSA.US)$In 2021, the first revenue was 0.039 billion, while the operating profit and net income have been in continuous loss for 5 years. The revenue continued to grow in the first three quarters of 2022, reaching 0.1 billion in Q3. The operating profit in Q3 also generated a profit of 0.046 billion, and the net income reached 0.22 billion due to a 0.18 billion income tax refund.
Currently, the trailing twelve months (TTM) price-to-earnings ratio is 7.2. If we exclude the impact of income tax refunds, the TTM price-to-earnings ratio is actually negative.
Due to having only one quarter of profit data, it is not possible to determine the sustainability of profitability. Continued observation is needed.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment